Patient Platforms Onboarding & eligibility flows Progress tracking & reminders Education, coaching & community Telehealth & Provider Tools Scheduling & care coordination Video consults & secure messaging Treatment protocols Medication Management E-prescribing to retail & compounding Refill & fulfillment tracking Insurance & Billing Eligibility checks, prior auths & appeals Subscriptions, cash-pay, and transparent billing Foundation for Growth HIPAA-ready infrastructure Integrations with your existing systems (like EHR, labs and pharmacy) Analytics & business insights Engagement & Retention Personalized nudges & reminders Gamification & milestone tracking Patient satisfaction surveys Experts in Digital Health Were Light-ita digital health product studio
Your dedicated medical team is just a click or a call away to adjust your plan, discuss nutrition, or celebrate your progress
Kieburtz K, Katz R, McGarry A, Olanow CW
Patients should not be asked to accept unproven therapies simply because effective, FDA-approved options are expensive or difficult to access. The Future of Compounded GLP-1s Is Uncertain Under U.S
Rationale, design and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease
